Display Settings:

Format

Send to:

Choose Destination
    J Neural Transm. 2009 Jul;116(7):913-20. Epub 2009 May 5.

    Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's disease.

    Source

    Department of Psychiatry, University Medicine Goettingen, Göttingen 37075, Germany.

    Abstract

    It has previously been shown that immune complexes (IC) of a given biomarker with class M immunoglobulins (IgM) provide better performances compared to the unbound biomarker in a number of cancer entities. In the present work, we investigated IC of IgM-Abeta as a potential biomarker for Alzheimer's disease (AD). Abeta-IgM concentration has been measured in 75 plasma samples from patients with AD, individuals with mild cognitive impairment (MCI), and healthy age- and sex-matched controls (HC). To characterize the fractions associated with Abeta, pooled plasma samples were subjected to gel-filtration analysis. Size-separated fractions were analyzed for the presence of Abeta using a sandwich ELISA assay. A strong reactivity was observed in the high molecular weight IgM (>500 kDa) and 150 kDa (IgG) fractions indicating that blood Abeta is strongly associated with antibodies. Using an ELISA assay detecting Abeta-IgM complexes, we observed that high levels of Abeta-IgMs were detectable in HC and MCI patients; however, there was no significant difference to the AD group.

    PMID:
    19415450
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2700872
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Fig. 2
    Fig. 1
    Fig. 3

      Supplemental Content

      Icon for Springer Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk